NNC0174-0833

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC0174-0833, covering 2023-07-18 to 2023-07-18. Get the full timeline:

Most recent: Clinical Trial Update: Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity. [Phase 2]

See pricing